2020
DOI: 10.3390/ijms21041462
|View full text |Cite
|
Sign up to set email alerts
|

Biapenem as a Novel Insight into Drug Repositioning against Particulate Matter-Induced Lung Injury

Abstract: The screening of biologically active chemical compound libraries can be an efficient way to reposition Food and Drug Adminstration (FDA)-approved drugs or to discover new therapies for human diseases. Particulate matter with an aerodynamic diameter equal to or less than 2.5 μm (PM2.5) is a form of air pollutant that causes significant lung damage when inhaled. This study illustrates drug repositioning with biapenem (BIPM) for the modulation of PM-induced lung injury. Biapenem was used for the treatment of seve… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
3
0
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
4
1

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 47 publications
0
3
0
1
Order By: Relevance
“…In many previous studies, the effect of improving PM 2.5 -caused damage such as pulmonary injury, airway inflammation, and oxidative stress was analyzed in comparison with DEX. Thus, we have scrutinized the efficacy of SFN compared to DEX (33)(34)(35)(36). In the present study, SFN reversed PM 2.5 -induced cellular toxicity.…”
Section: Discussionmentioning
confidence: 92%
“…In many previous studies, the effect of improving PM 2.5 -caused damage such as pulmonary injury, airway inflammation, and oxidative stress was analyzed in comparison with DEX. Thus, we have scrutinized the efficacy of SFN compared to DEX (33)(34)(35)(36). In the present study, SFN reversed PM 2.5 -induced cellular toxicity.…”
Section: Discussionmentioning
confidence: 92%
“…Биапенем -это новый парентеральный антибактериальный агент с широким спектром антибактериальной активности in vitro, охватывающий многие грамотрицательные и грамположительные аэробные и анаэробные бактерии, включая штаммы, продуцирующие β-лактамазы [11].…”
Section: экспериментальные статьиunclassified
“…Nowadays, the mainstream intervention is to use antiinflammatory drugs or antibiotics to interfere with the progression of pulmonary inflammation. 14,15 However, longterm use of anti-inflammatory drugs would induce severe side effects, including drug resistance and intestinal flora disturbance, which would limit their efficacy. 16 enhance the ability of loaded drugs to be specifically released at the site of disease, aiming to reducing damages to normal tissues.…”
Section: Introductionmentioning
confidence: 99%
“…Nowadays, the mainstream intervention is to use anti-inflammatory drugs or antibiotics to interfere with the progression of pulmonary inflammation. , However, long-term use of anti-inflammatory drugs would induce severe side effects, including drug resistance and intestinal flora disturbance, which would limit their efficacy . Recently, stimulus–response drug delivery systems (DDSs) have attracted great attention to enhance the ability of loaded drugs to be specifically released at the site of disease, aiming to reducing damages to normal tissues. , Among them, hollow mesoporous silica nanoparticles (HMSNs) are an ideal drug carrier due to their large surface area and unique high pore structure, which can effectively encapsulate different types of drugs. , In addition, the surface of HMSNs can be covered to achieve on-demand drug release as triggered by various stimuli, such as pH, redox potential, temperature, and ROS .…”
Section: Introductionmentioning
confidence: 99%